Drugs / Wenpi Qingwei granules
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04340297 | Jun 2020 → Dec 2021 | gastroesophageal reflux disease | Xiyuan Hospital of China Academy of Chinese Medical Sciences | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Wenpi Qingwei granules | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04340297 ↗ |
| Route | Oral | “Wenpi Qingwei granules are taken orally” NCT04340297 ↗ |